786 related articles for article (PubMed ID: 29107192)
21. Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.
Kaiser DW; Streur MM; Nagarakanti R; Whalen SP; Ellis CR
J Interv Card Electrophysiol; 2013 Sep; 37(3):241-7. PubMed ID: 23625091
[TBL] [Abstract][Full Text] [Related]
22. Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.
Maddox W; Kay GN; Yamada T; Osorio J; Doppalapudi H; Plumb VJ; Gunter A; McElderry HT
J Cardiovasc Electrophysiol; 2013 Aug; 24(8):861-5. PubMed ID: 23577951
[TBL] [Abstract][Full Text] [Related]
23. Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation.
Eitel C; Koch J; Sommer P; John S; Kircher S; Bollmann A; Arya A; Piorkowski C; Hindricks G
Europace; 2013 Nov; 15(11):1587-93. PubMed ID: 23703362
[TBL] [Abstract][Full Text] [Related]
24. Periprocedural stroke risk in patients undergoing catheter ablation for atrial fibrillation on uninterrupted warfarin.
Page SP; Herring N; Hunter RJ; Withycombe E; Lovell M; Wali G; Betts TR; Bashir Y; Dhinoja M; Earley MJ; Sporton SC; Rajappan K; Schilling RJ
J Cardiovasc Electrophysiol; 2014 Jun; 25(6):585-90. PubMed ID: 24641450
[TBL] [Abstract][Full Text] [Related]
25. Periprocedural Management of Cardiac Tamponade During Catheter Ablation for AF Under Uninterrupted DOAC and Warfarin.
Yanagisawa S; Inden Y; Ohguchi S; Nagao T; Fujii A; Tomomatsu T; Mamiya K; Okamoto H; Sakamoto Y; Shibata R; Murohara T
JACC Clin Electrophysiol; 2020 Jul; 6(7):786-795. PubMed ID: 32703560
[TBL] [Abstract][Full Text] [Related]
26. Catheter ablation for atrial fibrillation on uninterrupted warfarin: can it be done without echo guidance?
Page SP; Siddiqui MS; Finlay M; Hunter RJ; Abrams DJ; Dhinoja M; Earley MJ; Sporton SC; Schilling RJ
J Cardiovasc Electrophysiol; 2011 Mar; 22(3):265-70. PubMed ID: 21040095
[TBL] [Abstract][Full Text] [Related]
27. Interrupted or Uninterrupted Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation.
Yang P; Wang C; Ye Y; Huang T; Yang S; Shen W; Xu G; Wu Q
Cardiovasc Drugs Ther; 2020 Jun; 34(3):371-381. PubMed ID: 32232617
[TBL] [Abstract][Full Text] [Related]
28. Total Thrombus-Formation Analysis System (T-TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
Ito M; Kaikita K; Sueta D; Ishii M; Oimatsu Y; Arima Y; Iwashita S; Takahashi A; Hoshiyama T; Kanazawa H; Sakamoto K; Yamamoto E; Tsujita K; Yamamuro M; Kojima S; Hokimoto S; Yamabe H; Ogawa H
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26811167
[TBL] [Abstract][Full Text] [Related]
29. Lower Major Bleeding Rates with Direct Oral Anticoagulants in Catheter Ablation of Atrial Fibrillation: an Updated Meta-analysis of Randomized Controlled Studies.
Brunetti ND; Tricarico L; Tilz RR; Heeger CH; De Gennaro L; Correale M; Ieva R; Di Biase M; Rillig A; Metzner A; Santoro F
Cardiovasc Drugs Ther; 2020 Apr; 34(2):209-214. PubMed ID: 32080786
[TBL] [Abstract][Full Text] [Related]
30. Safety and Efficacy of Minimally Interrupted Dabigatran vs Uninterrupted Warfarin Therapy in Adults Undergoing Atrial Fibrillation Catheter Ablation: A Randomized Clinical Trial.
Nogami A; Harada T; Sekiguchi Y; Otani R; Yoshida Y; Yoshida K; Nakano Y; Nuruki N; Nakahara S; Goya M; Origasa H; Kihara Y; Hirao K; Aonuma K;
JAMA Netw Open; 2019 Apr; 2(4):e191994. PubMed ID: 31002317
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of uninterrupted rivaroxaban taken preoperatively for radiofrequency catheter ablation of atrial fibrillation compared to uninterrupted warfarin.
Tao S; Otomo K; Ono Y; Osaka Y; Hirao T; Koura K; Manno T; Ueshima D; Shimizu S; Isobe M; Hirao K
J Interv Card Electrophysiol; 2017 Mar; 48(2):167-175. PubMed ID: 27943112
[TBL] [Abstract][Full Text] [Related]
32. Safety of direct oral anticoagulants vs warfarin in patients with chronic liver disease and atrial fibrillation.
Goriacko P; Veltri KT
Eur J Haematol; 2018 May; 100(5):488-493. PubMed ID: 29444357
[TBL] [Abstract][Full Text] [Related]
33. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A
Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease.
Bhatia HS; Bailey J; Unlu O; Hoffman K; Kim RJ
Pacing Clin Electrophysiol; 2019 Nov; 42(11):1463-1470. PubMed ID: 31599969
[TBL] [Abstract][Full Text] [Related]
35. A Prospective Randomized Trial of Apixaban Dosing During Atrial Fibrillation Ablation: The AEIOU Trial.
Reynolds MR; Allison JS; Natale A; Weisberg IL; Ellenbogen KA; Richards M; Hsieh WH; Sutherland J; Cannon CP
JACC Clin Electrophysiol; 2018 May; 4(5):580-588. PubMed ID: 29798783
[TBL] [Abstract][Full Text] [Related]
36. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
Lakkireddy D; Reddy YM; Di Biase L; Vanga SR; Santangeli P; Swarup V; Pimentel R; Mansour MC; D'Avila A; Sanchez JE; Burkhardt JD; Chalhoub F; Mohanty P; Coffey J; Shaik N; Monir G; Reddy VY; Ruskin J; Natale A
J Am Coll Cardiol; 2012 Mar; 59(13):1168-74. PubMed ID: 22305113
[TBL] [Abstract][Full Text] [Related]
37. Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis.
Toso E; Peyracchia M; Matta M; D'Ascenzo F; Gaita F; Kornej J; Hindricks G; Jared Bunch T; Saliba W
Int J Cardiol; 2018 Nov; 270():172-179. PubMed ID: 29945808
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta-analysis.
Ge Z; Faggioni M; Baber U; Sartori S; Sorrentino S; Farhan S; Chandrasekhar J; Vogel B; Qadeer A; Halperin J; Reddy V; Dukkipati S; Dangas G; Mehran R
Cardiovasc Ther; 2018 Oct; 36(5):e12457. PubMed ID: 29971964
[TBL] [Abstract][Full Text] [Related]
39. Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events.
Nakamura K; Naito S; Sasaki T; Take Y; Minami K; Kitagawa Y; Motoda H; Inoue M; Otsuka Y; Niijima K; Yamashita E; Sugai Y; Kumagai K; Koyama K; Funabashi N; Oshima S
Europace; 2019 Feb; 21(2):259-267. PubMed ID: 29982562
[TBL] [Abstract][Full Text] [Related]
40. Real-World Investigation on Anticoagulation Management Before and After Catheter Ablation for Atrial Fibrillation in Japan - Periprocedural and Long-Term Outcomes.
Nogami A; Soejima K; Morishima I; Hiroshima K; Kato R; Sakagami S; Miura F; Okawa K; Kimura T; Inoue T; Takita A; Uno K; Kumagai K; Kurita T; Gosho M; Aonuma K;
Circ J; 2022 Dec; 87(1):50-62. PubMed ID: 35989303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
